CH617926A5 - - Google Patents

Download PDF

Info

Publication number
CH617926A5
CH617926A5 CH989675A CH989675A CH617926A5 CH 617926 A5 CH617926 A5 CH 617926A5 CH 989675 A CH989675 A CH 989675A CH 989675 A CH989675 A CH 989675A CH 617926 A5 CH617926 A5 CH 617926A5
Authority
CH
Switzerland
Prior art keywords
oxyphenylbutazone
derivatives
general formula
butyl
acid
Prior art date
Application number
CH989675A
Other languages
German (de)
English (en)
Inventor
Dieter Dr Rahtz
Henning Dr Koch
Erich Prof Dr Gerhards
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of CH617926A5 publication Critical patent/CH617926A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C243/00—Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/28—Two oxygen or sulfur atoms
    • C07D231/30—Two oxygen or sulfur atoms attached in positions 3 and 5
    • C07D231/32—Oxygen atoms
    • C07D231/34—Oxygen atoms with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
CH989675A 1974-07-29 1975-07-29 CH617926A5 (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2436882A DE2436882A1 (de) 1974-07-29 1974-07-29 Neue oxyphenylbutazon-derivate und ihre herstellung

Publications (1)

Publication Number Publication Date
CH617926A5 true CH617926A5 (el) 1980-06-30

Family

ID=5922046

Family Applications (2)

Application Number Title Priority Date Filing Date
CH989675A CH617926A5 (el) 1974-07-29 1975-07-29
CH460679A CH617927A5 (el) 1974-07-29 1979-05-17

Family Applications After (1)

Application Number Title Priority Date Filing Date
CH460679A CH617927A5 (el) 1974-07-29 1979-05-17

Country Status (20)

Country Link
US (1) US3968219A (el)
JP (1) JPS5136452A (el)
AT (1) AT344689B (el)
AU (1) AU8332175A (el)
BE (1) BE831855A (el)
CA (1) CA1062264A (el)
CH (2) CH617926A5 (el)
CS (1) CS197252B2 (el)
DD (1) DD122533A5 (el)
DE (1) DE2436882A1 (el)
DK (1) DK137009C (el)
ES (1) ES439810A1 (el)
FR (1) FR2280374A1 (el)
GB (1) GB1519498A (el)
HU (1) HU170518B (el)
IE (1) IE41639B1 (el)
IL (1) IL47768A (el)
NL (1) NL7509060A (el)
SE (1) SE415252B (el)
SU (1) SU593662A3 (el)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9915184D0 (en) * 1999-06-29 1999-09-01 Viral As A Compounds
IL142037A0 (en) * 2001-03-15 2002-03-10 Agis Ind 1983 Ltd Pharmaceutical compositions containing a non-steroidal anti-inflammatory drug
US20080262068A1 (en) * 2004-05-12 2008-10-23 A-Viral Asa Method of Tonic Treatment With Oxyphenbutazone Derivatives
US8729108B2 (en) * 2008-06-17 2014-05-20 Christopher J Dannaker Waterborne topical compositions for the delivery of active ingredients such as azelaic acid
AU2011231543B2 (en) 2010-03-26 2015-01-15 Galderma Research & Development Improved methods and compositions for safe and effective treatment of erythema
US9744168B2 (en) 2011-10-19 2017-08-29 Galderma Laboratories, Inc. Method of reducing facial flushing associated with systemic use of phosphodiesterase type 5 inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR5404M (el) * 1965-09-08 1967-09-25
FR2054447B1 (el) * 1969-07-03 1973-06-08 Synthelabo

Also Published As

Publication number Publication date
CA1062264A (en) 1979-09-11
AT344689B (de) 1978-08-10
BE831855A (fr) 1976-01-29
DE2436882A1 (de) 1976-02-19
GB1519498A (en) 1978-07-26
IL47768A (en) 1979-10-31
IL47768A0 (en) 1975-10-15
FR2280374B1 (el) 1980-04-30
DK137009B (da) 1978-01-02
IE41639B1 (en) 1980-02-13
FR2280374A1 (fr) 1976-02-27
SE7508543L (sv) 1976-01-30
CH617927A5 (el) 1980-06-30
ATA583675A (de) 1977-12-15
US3968219A (en) 1976-07-06
ES439810A1 (es) 1977-04-16
SE415252B (sv) 1980-09-22
DK137009C (da) 1978-05-22
DK344375A (da) 1976-01-30
DD122533A5 (el) 1976-10-12
JPS5136452A (el) 1976-03-27
IE41639L (en) 1976-01-29
SU593662A3 (ru) 1978-02-15
AU8332175A (en) 1977-01-27
HU170518B (el) 1977-06-28
NL7509060A (nl) 1976-02-02
CS197252B2 (en) 1980-04-30

Similar Documents

Publication Publication Date Title
DD158773A5 (de) Verfahren zur herstellung neuer glycerol-deri vate
CH640249A5 (de) Germaniumhaltiges organisches polymer und verfahren zu seiner herstellung.
DE2436883C2 (de) Benzimidazol-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
DE2812164A1 (de) Verwendung von wirkstoffvorlaeufern bei der bekaempfung bzw. behandlung von proliferativen hauterkrankungen
DE1801750A1 (de) Von Prostaglandinen abgeleitete Verbindungen und Verfahren zu ihrer Herstellung
CH617926A5 (el)
DE2948733A1 (de) Steroidspirothiazolidinderivate, verfahren zur herstellung derselben und diese enhaltende arzneimittel
DE2047105C3 (de) 17-Chlorsteroide und Verfahren zu ihrer Herstellung
DE2356654A1 (de) Protoberberinderivate und verfahren zur herstellung derselben
DE2617655C2 (de) Kortikoide, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Präparate
CH634083A5 (de) Verfahren zur herstellung neuer kortikoide.
DE1938218C3 (de) 9 a,21,21-Trichlor-ll ß-fluor- pregnene, Verfahren zu deren Herstellung sowie diese enthaltende Arzneimittel
EP0007347B1 (de) Lipidsenkende Alkylenglykolderivate und Verfahren zu ihrer Herstellung
DE2632678C2 (de) 6α-Fluor-12α-Halogen-Kortikoide und Verfahren zu ihrer Herstellung
CH630098A5 (en) Process for the preparation of derivatives of 9-chloroprednisolone
DE2323744B2 (de) 4,4'-Bismethylen-(3-methoxy-2-naphthoesäure-triamcinolon-acetonidester) und Verfahren zu dessen Herstellung
CH625254A5 (el)
DE2204358C2 (de) Verfahren zur Herstellung von Pregnansäure-Derivaten
DE2742982C2 (de) 9-Chlorprednisolon-Derivate, Verfahren zu deren Herstellung und diese enthaltendes pharmazeutisches Präparat
DE2328115A1 (de) Heterocyclische derivate, verfahren zu deren herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzungen
DE2601367B2 (de) Steroid [(1-Benzyl-1H-indazol-3-yl)-oxy]-essigsäure und Verfahren zu ihrer Herstellung
DE2145686C3 (de) 2-Chlor-S-sulfamylbenzoesäurederivate, Verfahren zu ihrer Herstellung und Arzneimittel, die diese Verbindungen enthalten
AT319493B (de) Verfahren zur Herstellung von neuen 21-Halogensteroiden
DE1668859C (de) 6 alpha, 9 alpha Difluorhydrocortison bzw prednisolon 17 valerat
AT372966B (de) Verfahren zur herstellung von neuen 9-fluorprednisolon-derivaten

Legal Events

Date Code Title Description
PL Patent ceased